APA

Pluda J. M., Yarchoan R., Smith P. D., McAtee N., Shay L. E., Oette D., Maha M., Wahl S. M., Myers C. E. & Broder S. (19900911). Subcutaneous recombinant granulocyte-macrophage colony-stimulating factor used as a single agent and in an alternating regimen with azidothymidine in leukopenic patients with severe human immunodeficiency virus infection. : Blood.

Chicago

Pluda J M, Yarchoan R, Smith P D, McAtee N, Shay L E, Oette D, Maha M, Wahl S M, Myers C E and Broder S. 19900911. Subcutaneous recombinant granulocyte-macrophage colony-stimulating factor used as a single agent and in an alternating regimen with azidothymidine in leukopenic patients with severe human immunodeficiency virus infection. : Blood.

Harvard

Pluda J. M., Yarchoan R., Smith P. D., McAtee N., Shay L. E., Oette D., Maha M., Wahl S. M., Myers C. E. and Broder S. (19900911). Subcutaneous recombinant granulocyte-macrophage colony-stimulating factor used as a single agent and in an alternating regimen with azidothymidine in leukopenic patients with severe human immunodeficiency virus infection. : Blood.

MLA

Pluda J M, Yarchoan R, Smith P D, McAtee N, Shay L E, Oette D, Maha M, Wahl S M, Myers C E and Broder S. Subcutaneous recombinant granulocyte-macrophage colony-stimulating factor used as a single agent and in an alternating regimen with azidothymidine in leukopenic patients with severe human immunodeficiency virus infection. : Blood. 19900911.